Page 49 - 《中国药房》2026年4期
P. 49

路抑制剂Compound C开展挽救实验。结果显示,Com‐                          学杂志,2025,53(1): 23-27,69.
          pound C 可显著逆转黄芩苷对 GDM 大鼠胰岛素抵抗的                     [12]  MIAO L C,ZHANG X T,ZHANG H L,et al. Baicalin
          改善作用,具体表现为削弱黄芩苷对 GDM 大鼠胰岛素                              ameliorates  insulin  resistance  and  regulates  hepatic  glu‐
          抵抗和糖脂代谢的调节作用,抑制其对 GDM 大鼠炎症                              cose metabolism via activating insulin signaling pathway
          反应和氧化应激的缓解作用,同时降低CTRP3、脂联素、                             in obese pre-diabetic mice[J]. Phytomedicine,2024,124:
                                                                  155296.
          GLUT4水平,上调SUV39H1、H3K9me3蛋白的表达。
                                                             [13]  ZHU Z Y,YU M,XU M F,et al. Baicalin suppresses ma-
              综上所述,黄芩苷可显著减轻 GDM 大鼠的氧化应
                                                                  crophage  JNK-mediated  adipose  tissue  inflammation  to
          激和炎症反应,提高体内CTRP3、脂联素、GLUT4水平,
                                                                  mitigate  insulin  resistance  in  obesity[J].  J  Ethnopharma‐
          从而改善其胰岛素抵抗;上述作用可能与激活 AMPK、
                                                                  col,2024,332: 118355.
          抑制SUV39H1介导的H3K9me3修饰有关。                           [14]  HASEI S,YAMAMOTOYA T,NAKATSU Y,et al. Car‐
          参考文献                                                    nosic acid and carnosol activate AMPK suppress expres‐
          [ 1 ]  THAWEETHAI T,SOETAN Z,JAMES K,et al. Distinct    sions  of  gluconeogenic  and  lipogenic  genes,and  inhibit
              insulin  physiology  trajectories  in  euglycemic  pregnancy   proliferation  of  HepG2  cells[J].  Int  J  Mol  Sci,2021,22
              and gestational diabetes mellitus[J]. Diabetes Care,2023,  (8): 4040.
              46(12): 2137-2146.                             [15]  ZHANG Y,WU Q F,LIU J,et al. Sulforaphane alleviates
          [ 2 ]  MALAZA N,MASETE M,ADAM S,et al. A systematic     high  fat  diet-induced  insulin  resistance  via AMPK/Nrf2/
              review to compare adverse pregnancy outcomes in women   GPx4 axis[J]. Biomed Pharmacother,2022,152: 113273.
              with  pregestational  diabetes  and  gestational  diabetes[J].   [16]  SU T,HE Y,HUANG Y,et al. Myeloid-derived grancal‐
              Int J Environ Res Public Health,2022,19(17): 10846.  cin instigates obesity-induced insulin resistance and meta‐
          [ 3 ]  ALSHEHRI  F  S.  New  developments  in  GLP-1  agonist   bolic inflammation in male mice[J]. Nat Commun,2024,
              therapy for gestational diabetes: systematic review on lira‐  15: 97.
              glutide,semaglutide,and  exenatide  from  ClinicalTrials.  [17]  GĘCA  T,KWIATEK  M,KRZYŻANOWSKI  A,et  al.
              gov[J]. Medicine,2025,104(40): e44917.              C1q/TNF-related  protein-3 (CTRP-3) and  pigment
          [ 4 ]  WEN Y Q,WANG Y Z,ZHAO C X,et al. The pharmaco‐   epithelium-derived  factor(PEDF)concentrations  in  pa‐
              logical  efficacy  of  baicalin  in  inflammatory  diseases[J].   tients  with  gestational  diabetes  mellitus:  a  case-control
              Int J Mol Sci,2023,24(11): 9317.                    study[J]. J Clin Med,2020,9(8): 2587.
          [ 5 ]  FANG D N,ZHENG C W,MA Y L. Effectiveness of Scu‐  [18]  AKHTAR Y,NAWAZ S,KHAN M S,et al. Relationship
              tellaria  baicalensis  Georgi  root  in  pregnancy-related  di-  of serum adiponectin levels with glycaemic status in preg‐
              seases: a review[J]. J Integr Med,2023,21(1): 17-25.  nant  women[J].  J Ayub  Med  Coll Abbottabad,2022,34
          [ 6 ]  ENTEZARI  M,HASHEMI  D,TAHERIAZAM A,et  al.     (2): 235-238.
              AMPK  signaling  in  diabetes  mellitus,insulin  resistance   [19]  HERMAN R,KRAVOS N A,JENSTERLE M,et al. Met‐
              and diabetic complications: a pre-clinical and clinical in‐  formin and insulin resistance: a review of the underlying
              vestigation[J]. Biomed Pharmacother,2022,146: 112563.  mechanisms behind changes in GLUT4-mediated glucose
          [ 7 ]  KOWLURU R A,RADHAKRISHNAN R,MOHAMMAD             transport[J]. Int J Mol Sci,2022,23(3): 1264.
              G. Regulation of Rac1 transcription by histone and DNA   [20]  HUANG S Z,LIANG H M,CHEN Y T,et al. Hypoxan‐
              methylation in diabetic retinopathy[J]. Sci Rep,2021,11  thine  ameliorates  diet-induced  insulin  resistance  by  im‐
              (1): 14097.                                         proving hepatic lipid metabolism and gluconeogenesis via
          [ 8 ]  BARADARAN RAHIMI V,ASKARI V R,HOSSEINZADEH       AMPK/mTOR/PPARα  pathway[J].  Life  Sci,2024,357:
              H. Promising influences of Scutellaria baicalensis and its   123096.
              two  active  constituents,baicalin,and  baicalein,against   [21]  LUO Y F,FAN C C,YANG M J,et al. CD74 knockout
              metabolic syndrome: a review[J]. Phytother Res,2021,35  protects  against  LPS-induced  myocardial  contractile  dys‐
              (7): 3558-3574.                                     function  through  AMPK-Skp2-SUV39H1-mediated  de‐
          [ 9 ]  袁飞飞,陈芬,习红丽,等 . 蛇床子素调节 cGAS-STING                 methylation of BCLB[J]. Br J Pharmacol,2020,177(8):
              信号通路对妊娠糖尿病大鼠炎症反应的改善作用研究                             1881-1897.
              [J]. 中国免疫学杂志,2025,41(7): 1725-1729.            [22]  SUN K,CHEN M H,KONG X Y,et al. Cardiac-specific
          [10]  雍乐,王安,陈林,等 . 黄芩苷调控 Nrf2、HO-1 缓解妊娠                 SUV39H1 knockout ameliorates high-fat diet induced dia‐
              期糖尿病大鼠氧化应激损伤[J]. 广州中医药大学学报,                         betic cardiomyopathy via regulating Hmox1 transcription
              2025,42(5): 1212-1220.                              [J]. Life Sci,2025,360: 123258.
          [11]  赵彩霞,刘建芳,刘宏,等. 雷公藤甲素对心力衰竭大鼠                                  (收稿日期:2025-09-04  修回日期:2026-01-26)
              心肌损伤及 AMPK/mTOR 通路的影响[J]. 中南医学科                                                     (编辑:张元媛)



          中国药房  2026年第37卷第4期                                                 China Pharmacy  2026 Vol. 37  No. 4    · 455 ·
   44   45   46   47   48   49   50   51   52   53   54